Loading...
Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...
Na minha lista:
| Udgivet i: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308315/ https://ncbi.nlm.nih.gov/pubmed/30622514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00777 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|